Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Naoaki Ichikawa"'
Autor:
Yuko Fujikawa, Yuki Hiroshima, Wataru Takeda, Hikaru Kobayashi, Toshimitsu Ueki, Mayumi Ueno, Masahiko Sumi, Keijiro Sato, Naoaki Ichikawa, Takehiko Kirihara, Ikuo Shimizu
Publikováno v:
Blood. 120:4849-4849
Abstract 4849 Background: Peripheral T-cell lymphoma (PTCL) is an intractable entity with limited response to CHOP-like regimens or more intensive regimens. Although some relapsed or refractory patients may benefit from allogeneic stem cell transplan
Autor:
Daigo Akahane, Yuko Fujikawa, Mayumi Ueno, Ikuo Shimizu, Masahiko Sumi, Hikaru Kobayashi, Keijiro Sato, Toshimitsu Ueki, Naoaki Ichikawa, Yoichi Okazaki
Publikováno v:
Blood. 118:4214-4214
Abstract 4214 Introduction: Although pathological diagnosis is an essential component of managing malignant lymphoma and other malignancies, intraabdominal lesions are generally difficult to approach due to the invasiveness of abdominal surgery. We r
Autor:
Naoaki Ichikawa, Mayumi Ueno, Kentaro Nasu, Ikuo Shimizu, Hikaru Kobayashi, Masahiko Sumi, Toshimitsu Ueki
Publikováno v:
Blood. 114:4341-4341
Abstract 4341 Relapses in acute leukemia (AL) following allogeneic stem cell transplantation (allo-SCT), particularly those relapses within 1 year after transplantation, are often refractory to induction chemotherapy. Patients with this type of relap
Autor:
Shigeo Nakamura, Kazuyuki Shimada, Hiroshi Miwa, Kosei Matsue, Masataka Okamoto, Yasufumi Masaki, Kazuhito Yamamoto, Nozomi Niitsu, Takuhei Murase, Naoaki Ichikawa, Tomohiro Kinoshita, Motoko Yamaguchi, Morio Matsumoto, Ako Kikuchi, Takashi Yoshida, Norifumi Tsukamoto, Hideki Asaoku, Makoto Kashimura, Yoshio Saburi, Hiroshi Kosugi, Tomoki Naoe, Kazuo Tamura
Publikováno v:
Blood. 112:4933-4933
Central nervous system (CNS) recurrence is a serious and usually fatal complication in the clinical course of aggressive lymphoma. Although our recent report suggested that the improvement of clinical outcomes in intravascular large B-cell lymphoma (
Autor:
Makoto Kashimura, Tomoki Naoe, Norifumi Tsukamoto, Hiroshi Kosugi, Morio Matsumoto, Kazuyuki Shimada, Kazuhito Yamamoto, Hiroshi Miwa, Motoko Yamaguchi, Shigeo Nakamura, Yoshio Saburi, Kosei Matsue, Masataka Okamoto, Nozomi Niitsu, Ako Kikuchi, Naoaki Ichikawa, Hideki Asaoku, Kinoshita Tomohiro, Yasufumi Masaki, Takuhei Murase
Publikováno v:
Blood. 110:3439-3439
Background: Intravascular large B-cell lymphoma (IVLBCL) is a rare subtype of extranodal diffuse large B-cell lymphoma (DLBCL) with poor prognosis. Recently, the addition of rituximab to CHOP regimen has significantly improved the outcome of DLBCL. H